tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PRRUF Stock Latest News

Immutep sees progress from Phase I study of LAG-3 agonist for autoimmune disease
The FlyImmutep sees progress from Phase I study of LAG-3 agonist for autoimmune disease
4d ago
IMMP
Insignia Financial Ceases to Be Substantial Holder in Immutep
PremiumCompany Announcements
Insignia Financial Ceases to Be Substantial Holder in Immutep
4d ago
Immutep Reports Positive Phase I Progress for First-in-Class Autoimmune Drug IMP761
PremiumCompany Announcements
Immutep Reports Positive Phase I Progress for First-in-Class Autoimmune Drug IMP761
5d ago
UBS Group Ceases to Be Substantial Shareholder in Immutep
PremiumCompany Announcements
UBS Group Ceases to Be Substantial Shareholder in Immutep
5d ago
Immutep downgraded to Hold from Buy at Maxim
PremiumThe Fly
Immutep downgraded to Hold from Buy at Maxim
10d ago
IMMP
Adobe downgraded, Nio upgraded: Wall Street’s top analyst calls
PremiumThe FlyAdobe downgraded, Nio upgraded: Wall Street’s top analyst calls
10d ago
AA
PD
Immutep says IDMC recommends discontinuation for TACTI-004 Phase III study
Premium
The Fly
Immutep says IDMC recommends discontinuation for TACTI-004 Phase III study
10d ago
IMMP
Immutep downgraded to Neutral from Outperform at Baird
Premium
The Fly
Immutep downgraded to Neutral from Outperform at Baird
10d ago
IMMP
Immutep downgraded to Market Perform from Outperform at Citizens
PremiumThe Fly
Immutep downgraded to Market Perform from Outperform at Citizens
10d ago
IMMP
Immutep Trading Resumes on ASX After Key Phase III Trial Update
PremiumCompany Announcements
Immutep Trading Resumes on ASX After Key Phase III Trial Update
11d ago
Immutep Halts Pivotal Lung Cancer Trial After Futility Review
PremiumCompany Announcements
Immutep Halts Pivotal Lung Cancer Trial After Futility Review
11d ago
Immutep Shares Suspended Pending Key Phase III Trial Futility Update
PremiumCompany Announcements
Immutep Shares Suspended Pending Key Phase III Trial Futility Update
13d ago
Immutep Halts Trading Ahead of Key Phase III Trial Futility Analysis
PremiumCompany AnnouncementsImmutep Halts Trading Ahead of Key Phase III Trial Futility Analysis
17d ago
Immutep Doubles Half-Year Loss as R&D Spend Surges Despite New Collaboration Revenue
Premium
Company Announcements
Immutep Doubles Half-Year Loss as R&D Spend Surges Despite New Collaboration Revenue
26d ago
Immutep initiated with an Outperform at Citizens
Premium
The Fly
Immutep initiated with an Outperform at Citizens
1M ago
IMMP
Immutep achieves 50% enrollment in global TACTI-004 Phase III trial
PremiumThe Fly
Immutep achieves 50% enrollment in global TACTI-004 Phase III trial
1M ago
IMMP
Immutep Hits 50% Enrolment Milestone in Global Phase III Lung Cancer Trial
PremiumCompany Announcements
Immutep Hits 50% Enrolment Milestone in Global Phase III Lung Cancer Trial
2M ago
Immutep reports Q2 cash receipts from customers A$4,000
PremiumThe Fly
Immutep reports Q2 cash receipts from customers A$4,000
2M ago
IMMP
Immutep Secures Dr. Reddy’s Partnership and Strengthens Clinical, Financial Position
PremiumCompany Announcements
Immutep Secures Dr. Reddy’s Partnership and Strengthens Clinical, Financial Position
2M ago
Immutep announces update on IMP761 from Phase I study
PremiumThe FlyImmutep announces update on IMP761 from Phase I study
3M ago
IMMP
Immutep Reports Promising Phase I Data for First-in-Class Autoimmune Antibody IMP761
Premium
Company Announcements
Immutep Reports Promising Phase I Data for First-in-Class Autoimmune Antibody IMP761
3M ago
Immutep announces progress in global TACTI-004 Phase III, enrollment continues
Premium
The Fly
Immutep announces progress in global TACTI-004 Phase III, enrollment continues
3M ago
MRK
IMMP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >